Title: Clinical and Metabolic changes after the Non- surgical Periodontal Therapy in patients with Type-2 Diabetes Mellitus with Chronic periodontitis with or without the Systemic administration of Azithromycin - A Randomized Controlled Clinical Trial

Authors: Dr Madanika P, Dr Suryakanth Malgikar

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i3.168

Abstract

Background & Objectives: There is growing evidence that periodontitis may affect general health. Periodontal disease is now recognized as the sixth complication of diabetes. It has been suggested that an alteration in glucose metabolism occurs as a result of antibacterial periodontal therapy. The present study is aimed to evaluate the clinical and metabolic changes in type-2 diabetic patients with chronic periodontitis after non-surgical periodontal therapy with or without the systemic administration of azithromycin.
Method: In our study24 patients with type-2 diabetes having chronic periodontitis were included. Group I included 12 patients who underwent scaling and root planing (SRP) only and group II 12 patients who underwent SRP with concomitant systemic administration of azithromycin 500mg once daily for 3 days. At baseline, plaque index (PI), gingival index (GI), probing depths (PD) were recorded and glycated haemoglobin (HbA1c) levels were evaluated. Patients were followed for 30-90 days.
Results: The mean decreasein glycosylated hemoglobin (HbA1c) was 0.18± 0.5 after nonsurgical periodontal treatment in group I on comparing the baseline (8.98± 0.99) and final values (8.8± 1.10), and in group II was 1.18± 0.47on comparing the baseline (9.01± 1.18) and final values (3.36± 1.87) proved statistically significant (P≤ 0.05).
Conclusion: A decrease in HbA1c was observed in group II (SRP+Azithromycin 500mg once daily3 days) thus indicating improved blood glucose control in Type 2 diabetics with periodontal disease compared to group I (SRP only).
Keywords: Non-surgical therapy; Haemoglobin A1c; Diabetes Mellitus; Chronic Periodontitis; Periodontal Disease; Antibiotics; Azithromycin; Diabetes Mellitus.

References

  1. Suryakanth Malgikar, Harinath Reddy S, Vidya Sagar S, Satyanarayana D, Vikram Reddy G, Juliet Josephin J. Clinical effects of photodynamic and low-level laser therapies as an adjunct to scaling and root planing of chronic periodontitis: A splitmouth randomized controlled clinical trial. Indian Journal of Dental Research 2016; 27(2): 121-126.
  2. Tara B. Taieb Ali, Renukanth P. Chetan Raman & Rathna D. Vaithilingam (2011). Relationship between periodontal disease and diabetes mellitus: an Asian perspective. Periodontology 2000 56: 258-268.
  3. Stewart, J. E., Wager, K. A., Friedlander, A. H., & Zadeh, H. H. (2001). The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. Journal of clinical periodontology28, 306-310.
  4. Strauss, S M, Tuthill, J M A, Singh,G, Rindskopf, D, Maggiore, J A, Schoor, R Anya Brodsky, Einhorn, A, Hochstein, A, Russell, S and Rosedale M. A Novel Intra-Oral Diabetes Screening Approach in Periodontal Patients: Results of a Pilot Study. J Periodontol 2012 June; 83(6): 699–706.
  5. Antonio Renatus, Jorg Herrmann, Antje Schonfelder, Fabian Schwarzenberger, Holger Jentsch. Clinical Efficacy of Azithromycin as an Adjunctive Therapy to Non-Surgical Periodontal Treatment of Periodontitis: A Systematic Review and Meta-Analysis. Journal of Clinical and Diagnostic Research. 2016 Jul, Vol-10(7): ZE01-ZE07.
  6. Muller HP, Holderrieth S, Burkhardt U, Hoffler U. In vitro antimicrobial suscep-tibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics. J Clin Periodontol. 2002; 29:736–42.
  7. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964; 22: 121-135.
  8. Loe M, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 22: 121-126.
  9. Altman DG, Bland JM. How to randomize. BMJ 1999; 319: 703-704.
  10. Emingil G, Han B, Ozdemir G, Tervahartiala T, Vural C, Atilla G, et al. The effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis. J Periodont Res. 2012; 47: 729–39.
  11. Gomi K, Yashima A, Iino F. Drug concentration in inflamed periodontal tissues after systemically administered azithro-mycin. J Periodontol 2007; 78:918–23.
  12. Oteo A, Herrera D, Figuero E, O’Connor A, Gonzalez I, Sanz M. Azithromycin as an adjunct to scaling and root planing in the treatment of Porphyromonas gingivalis-associated periodontitis: a pilot study. J Clin Periodontol. 2010; 37:1005–15.
  13. Smith SR, Foyle DM, Daniels J, Joyston-Bechal S, Smales FC, Sefton A, et al. A double-blind placebo-controlled trial of azithromycin as an adjunct to nonsurgical treatment of periodontitis in adults: clinical results. J Clin Periodontol. 2002; 29:54–61.
  14. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiological perspective. Annals of Periodontology 2001;6(1):99–112.
  15. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Annals of Periodontology 1998; 3(1):51–61.

Corresponding Author

Dr Madanika P

PES Institute of Medical Sciences & Research

NH 219, Chitoor District, Kuppam, Andhra Pradesh 517425